HUMANIZED ANTIBODIES

The present disclosure provides humanized antibodies, including antibodies comprising an ultralong CDR3 and uses thereof.

Saved in:
Bibliographic Details
Main Authors Bazirgan, Omar, Smider, Vaughn, Mao, Hongyuan Helen
Format Patent
LanguageEnglish
Published 16.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides humanized antibodies, including antibodies comprising an ultralong CDR3 and uses thereof.
Bibliography:Application Number: US202016735070